Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$60,627,678
-$4,790,962 QoQ
Shares Held
711,676
-28.3% QoQ
Ownership
0.512%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#46
of 477 holders
Holding Since
Sep 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Derivatives in CYTK
reported options exposure · as of Jun 30, 2026CallValue
$1,652,686
CallShares
19,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names. CYTK ranks #7 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
1,665,102 | $221,008,988 | |
| 2 | INSM |
INSMED Inc
|
1,326,430 | $141,423,966 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,230,052 | $91,614,272 | |
| 4 | ABVX |
Abivax S.A.
|
603,840 | $80,467,718 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
145,005 | $72,028,333 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
2,016,379 | $63,032,007 | |
| 7 | CYTK |
Cytokinetics Inc
This page
|
711,676 | $60,627,678 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
1,054,613 | $60,344,955 |
All Filings in CYTK
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $60,627,678 | 711,676 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $1,652,686 | 19,400 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $6,960,096 | 105,600 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $65,418,640 | 992,545 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $22,779,090 | 358,500 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $19,818,576 | 360,600 | Call | Sole | 2025-11-14 | |
| 2024-09-30 | $248,160 | 4,700 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $6,203,313 | 117,487 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $32,582,064 | 601,367 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $10,895,598 | 201,100 | Call | Sole | 2024-08-14 | |
| 2024-03-31 | $17,604,621 | 251,100 | Call | Sole | 2024-05-13 | |
| 2024-03-31 | $47,328,596 | 675,062 | Shares | Other | 2024-05-13 | |
| 2024-03-31 | $10,642,698 | 151,800 | Put | Sole | 2024-05-13 | |
| 2023-12-31 | $5,259,870 | 63,000 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $34,492,808 | 413,137 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $28,394,949 | 340,100 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $1,334,538 | 45,300 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $34,729,745 | 1,178,878 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $34,953,373 | 1,071,532 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $33,501,020 | 952,004 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $40,386,114 | 881,408 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $13,723,364 | 283,248 | Shares | Other | 2022-11-15 | |
| 2022-06-30 | $7,411,626 | 188,639 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $451,743 | 9,911 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,319,342 | 36,915 | Shares | Sole | 2021-12-01 | |
| 2020-09-30 | $866,000 | 40,000 | Call | Sole | 2020-11-16 | |
| 2020-09-30 | $2,712,701 | 125,298 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||